Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on German Science & Technology Today.
Press releases published on April 21, 2025
Orlando Magic Venture Challenge Names Five Early-Stage Companies
EIN Presswire
·
April 21, 2025
DeVos family, LEAD providing more than $750,000 in total investment capital to the companies through the challenge ORLANDO, FL, UNITED STATES, April 21, 2025 /EINPresswire.com/ -- As part of the Orlando Magic and LEAD’s continuing commitment to …
Meet AEssenseGrows and Endo Canna: See New Products and Production Supply at ICBC Berlin 2025
EIN Presswire
·
April 21, 2025
AEssenseGrows provides consulting services …
Prospera Energy Announces Monthly Operations Update
GlobeNewswire
·
April 21, 2025
CALGARY, Alberta, April 21, 2025 (GLOBE NEWSWIRE) -- Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) ("Prospera", “PEI” or the "Corporation") Prospera Energy remains committed to providing stakeholders with transparent, timely, and data-driven updates on …
Process Insights Unveils the Lab NIR-O: A High-Precision NIR Spectroscopy Breakthrough
EIN Presswire
·
April 21, 2025
Process Insights Launches the GUIDED WAVE Lab NIR-O: Advanced NIR Spectroscopy for Unmatched Precision HOUSTON, TX, UNITED STATES, April 21, 2025 /EINPresswire.com/ -- Process Insights, a global leader in industrial process monitoring solutions, is …
ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat
GlobeNewswire
·
April 21, 2025
MADRID and CAMBRIDGE, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that the European Patent Office has …
Affimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
GlobeNewswire
·
April 21, 2025
MANNHEIM, Germany, April 21, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it has received a written notice (the “ …